PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation

Sun Young Kim, Sewoon Kim, Jeong Mi Kim, Eek hoon Jho, Seonyang Park, Doyeun Oh, Hye Sook Yun-Choi

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Impaired responsiveness of platelets to epinephrine (epi) and other catecholamines (CA) has been reported in approximately 20% of the healthy Korean and Japanese populations. In the present study, platelet aggregation induced by epi was potentiated by RO 31-8220 (RO) or Gö 6983 (Gö). Phosphorylated Akt (p-Akt) was very low in epi-stimulated PRP from CA-hypo-responders (CA-HY), whereas it was detected in those from CA-good responders (CA-GR). RO and Gö increased p-Akt, one of the major downstream effectors of phosphoinositol-3 kinase (PI3K), in epi-stimulated PRP from both groups. Wort-mannin, a PI3K inhibitor, attenuated the RO or Gö-induced potentiation of p-Akt in epi-stimulated PRP, suggesting positive effects for RO and Gö on PI3K. TXA2 formation was increased by the addition of either RO or Gö in epi-stimulated platelets. The present data also suggest that impaired Akt phosphor-ylation may be responsible for epinephrine hypo-responsiveness of platelets.

Original languageEnglish
Pages (from-to)140-145
Number of pages6
JournalBMB Reports
Volume44
Issue number2
DOIs
StatePublished - Feb 2011

Keywords

  • Akt
  • Epinephrine
  • Gö 6983
  • Platelet aggregation
  • RO 31-8220

Fingerprint

Dive into the research topics of 'PKC inhibitors RO 31-8220 and Gö 6983 enhance epinephrine-induced platelet aggregation in catecholamine hypo-responsive platelets by enhancing Akt phosphorylation'. Together they form a unique fingerprint.

Cite this